Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

UK Mortgage Rates Hit Pre‑Mini‑Budget Lows as China’s $1 Trillion Trade Surplus Shifts the Global Outlook

UK Mortgage Rates Hit Pre‑Mini‑Budget Lows as China’s $1 Trillion Trade Surplus Shifts the Global Outlook

London / Beijing – 8 December 2025 – Homeowners in the UK woke up today to the most competitive mortgage market since before the turmoil of the 2022 mini‑budget, just as China confirmed its trade surplus has smashed through the $1 trillion mark for the first time. Together, these stories tell you something important: the global backdrop for interest rates, mortgages and inflation is changing – again. Below, we break down what happened today, why lenders are talking about a “full‑scale price war”, how China’s export machine is still powering ahead despite years of tariffs, and what all of this
8 December 2025
·
NIO Stock on December 8, 2025: Deliveries Surge, Shares Slide and Analysts Split on the Outlook

NIO Stock on December 8, 2025: Deliveries Surge, Shares Slide and Analysts Split on the Outlook

NIO Inc. (NYSE: NIO), often branded the “Tesla of China,” is closing 2025 with a strikingly mixed picture: record deliveries and improving margins on one side, a bruised share price and persistent losses on the other. As of the U.S. session on December 8, 2025, NIO’s New York–listed shares trade around $5.12, up modestly on the day but still well below recent highs. Data from independent equity research platforms indicates the stock has fallen roughly 29% over the past month, even while remaining about 12% higher than a year ago. Simply Wall St Against that backdrop, new data on November
8 December 2025
··
Recursion Pharmaceuticals (RXRX) Stock Jumps on Positive FAP Trial Data: Latest News, AI Drug Discovery Outlook and Analyst Forecasts

Recursion Pharmaceuticals (RXRX) Stock Jumps on Positive FAP Trial Data: Latest News, AI Drug Discovery Outlook and Analyst Forecasts

Recursion Pharmaceuticals’ stock is back in the spotlight on 8 December 2025 after the company reported encouraging mid‑stage trial results for its AI‑discovered drug REC‑4881 in a rare, cancer‑linked condition called familial adenomatous polyposis (FAP). The news gives investors something they’ve been waiting on for years: early clinical proof that Recursion’s AI‑driven platform might actually work in real patients. GlobeNewswire+1 Shares of Recursion (ticker: RXRX) traded in the mid‑$4 range on Monday, up low single digits intraday after jumping as much as around 6% in pre‑market trading on the back of the data, according to Reuters and Benzinga. Reuters+1 Below
8 December 2025
···
Nvidia (NVDA) Stock on December 8, 2025: CUDA 13.1, Synopsys Deal and SAFE CHIPS Act Steer the Next AI Chapter

Nvidia (NVDA) Stock on December 8, 2025: CUDA 13.1, Synopsys Deal and SAFE CHIPS Act Steer the Next AI Chapter

(for editors) Nvidia stock is trading around $183 on December 8, 2025, as investors digest a massive CUDA 13.1 software update, a $2 billion Synopsys deal, blockbuster Q3 FY26 earnings, and new export-control legislation. Here’s how the latest news and Wall Street forecasts shape the outlook for NVDA. Key takeaways Nvidia stock today: price, performance and valuation As of early trading on December 8, 2025, Nvidia Corporation (NASDAQ: NVDA) is changing hands around $183 per share, with an intraday range near $182–$186. Investing.com Key snapshot: For context, U.S. equity indices are hovering just below all‑time highs as investors await this
8 December 2025
··
BigBear.ai Stock (BBAI) Today: Price, Middle East Expansion, Dilution Risks and 2026 Forecast

BigBear.ai Stock (BBAI) Today: Price, Middle East Expansion, Dilution Risks and 2026 Forecast

As of 8 December 2025, BigBear.ai Holdings, Inc. (NYSE: BBAI) sits right at the intersection of three noisy stories: the AI defense boom, aggressive capital-raising, and a very enthusiastic stock market. The share price is trading in the mid‑$6 range (around $6.4–$6.5 intraday), giving BigBear.ai a market capitalization of roughly $3 billion.Stock Titan+1 Year‑to‑date, the stock is up about 49%, vastly outpacing the S&P 500, and it has climbed roughly 36% over the past six months.Yahoo Finance+1 At the same time, revenue is falling, the business remains unprofitable, and the company has just doubled its authorized share count, giving it
8 December 2025
··
Plug Power Stock Today: NASA Contract, Cash Lifeline and a Divided Wall Street – What December 8, 2025 Really Changes for PLUG

Plug Power Stock Today: NASA Contract, Cash Lifeline and a Divided Wall Street – What December 8, 2025 Really Changes for PLUG

Plug Power Inc. (NASDAQ: PLUG) is back in the spotlight on December 8, 2025, as a cluster of fresh news hits the stock: a rescheduled special shareholder meeting, a first-ever liquid hydrogen contract with NASA, a new green hydrogen deal in France and a flurry of updated analyst views. At the same time, the numbers behind PLUG stock still tell a story of heavy losses, aggressive restructuring and a very patient Wall Street. Where PLUG Stock Stands on December 8, 2025 As of late morning on December 8, Plug Power shares are trading around $2.13 in real time, giving the
8 December 2025
··
Ondas Holdings (ONDS) Stock on December 8, 2025: New Ukrainian Drone Deal Caps a Wild Year for This Autonomous Defense Play

Ondas Holdings (ONDS) Stock on December 8, 2025: New Ukrainian Drone Deal Caps a Wild Year for This Autonomous Defense Play

Date: December 8, 2025 – For informational purposes only; not investment advice. Ondas Holdings at a Glance: A Microcap That Became a $3.4 Billion Defense Platform Ondas Holdings Inc. (NASDAQ: ONDS) has had the kind of 12‑month run that makes risk managers sweat. As of late trading on December 8, 2025, ONDS is changing hands around $9.20–$9.30 per share, with a market cap of roughly $3.4 billion.StockAnalysis+1 According to StockAnalysis, Ondas’ market value has surged to $3.44 billion, up an eye‑watering 6,537% over the past year as investors repriced the company from a speculative drone-and-wireless microcap into a cash‑rich autonomous
8 December 2025
··
HanesBrands (HBI) Stock After the Gildan Takeover: What Delisting, Deal Terms and New Forecasts Mean for Investors (Dec 8, 2025)

HanesBrands (HBI) Stock After the Gildan Takeover: What Delisting, Deal Terms and New Forecasts Mean for Investors (Dec 8, 2025)

Updated December 8, 2025 HanesBrands Inc. (formerly NYSE: HBI) has effectively disappeared as a stand‑alone stock. On December 1, 2025, Gildan Activewear Inc. (NYSE: GIL) closed its long‑awaited acquisition of HanesBrands, turning the iconic underwear maker into a wholly owned subsidiary and triggering the suspension and planned delisting of HBI shares from the New York Stock Exchange. GlobeNewswire+1 For investors who owned HanesBrands stock, the story has shifted from “What is HBI worth?” to “What is my new stake in Gildan worth?” This article walks through the latest news, deal mechanics, analyst forecasts and strategic context as of December 8,
8 December 2025
···
Warner Bros. Discovery Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery, Inc. (NASDAQ: WBD) is suddenly less about box office and more about boardrooms. On Monday, December 8, 2025, the stock jumped sharply after Paramount Skydance lobbed a $30-per-share hostile all‑cash offer at the company, directly challenging Netflix’s already-announced acquisition of Warner Bros.’ studios and streaming assets.TheWrap+1 The result: WBD has turned into one of the most hotly contested takeover stories in modern media — and the stock price now reflects a tug-of-war between deal math, regulatory risk and still-imperfect fundamentals. Where WBD Stock Stands Today As of early afternoon on December 8, Warner Bros. Discovery shares were
8 December 2025
Dyne Therapeutics Stock Soars on Duchenne Trial Data: What December 8 Means for DYN Investors

Dyne Therapeutics Stock Soars on Duchenne Trial Data: What December 8 Means for DYN Investors

Published: December 8, 2025 Dyne Therapeutics (NASDAQ: DYN) is back on biotech investors’ radar after releasing highly anticipated topline data from its Phase 1/2 DELIVER trial in Duchenne muscular dystrophy (DMD), sending the stock sharply higher on Monday. By mid‑afternoon on December 8, Dyne shares were trading around $23.20, up roughly 14% on the day, after opening at $21.59 and touching an intraday high near $25.68. The move caps a volatile year in which the stock has already seen multiple double‑digit swings tied to trial updates, analyst calls, and sector M&A. Below is a breakdown of what changed today, how
8 December 2025
IBM to Acquire Confluent for $11 Billion in All‑Cash Deal to Power Enterprise AI Data Streaming

IBM to Acquire Confluent for $11 Billion in All‑Cash Deal to Power Enterprise AI Data Streaming

December 8, 2025 International Business Machines (IBM) has agreed to acquire data‑streaming specialist Confluent in an all‑cash transaction valued at $11 billion, the latest sign that Big Tech’s AI arms race is shifting from models to the real‑time data infrastructure that feeds them. Under a definitive agreement announced on Monday, IBM will buy all of Confluent’s outstanding common shares for $31 per share in cash, implying an enterprise value of $11 billion.IBM Newsroom+1 The companies expect the deal to close by mid‑2026, pending Confluent shareholder and regulatory approvals.IBM Newsroom+1 IBM says the acquisition will allow it to build a “smart
8 December 2025
····
Bank of Canada Expected to Hold Interest Rate at 2.25% on December 10 as Fed Prepares to Cut

Bank of Canada Expected to Hold Interest Rate at 2.25% on December 10 as Fed Prepares to Cut

Ottawa / Toronto / New York – December 8, 2025 With just two days to go before the Bank of Canada’s final interest rate announcement of 2025, markets and economists are almost unanimous: the Bank will likely hold its key rate at 2.25% on Wednesday, even as the U.S. Federal Reserve is widely expected to deliver another quarter‑point cut the same day. Bank of Canada+2Reuters+2 The twin decisions, landing within minutes of each other on December 10, will cap a year defined by aggressive rate cuts, tariff‑driven uncertainty and a surprisingly resilient North American economy. When and how the Bank
8 December 2025
·
CRH plc Stock: S&P 500 Debut, Buybacks and 2026 Infrastructure Tailwinds — Latest News & Forecasts (8 December 2025)

CRH plc Stock: S&P 500 Debut, Buybacks and 2026 Infrastructure Tailwinds — Latest News & Forecasts (8 December 2025)

Dublin / New York – December 8, 2025 CRH plc (NYSE: CRH; LON: CRH), the Dublin‑headquartered building materials giant, is closing out 2025 with a flurry of catalysts: confirmation it will join the S&P 500 later this month, fresh 52‑week highs in London, strong third‑quarter results, an expanded share buyback, and increasingly bullish analyst forecasts tied to U.S. infrastructure spending. Business Wire+2MarketBeat+2 Below is a structured rundown of today’s key developments (8 December 2025), together with the most recent forecasts and expert commentary on CRH stock. CRH to Join the S&P 500 on December 22 CRH confirmed this morning via
8 December 2025
···
IBM Stock After the $11 Billion Confluent Deal: Price, Forecasts and AI Strategy in December 2025

IBM Stock After the $11 Billion Confluent Deal: Price, Forecasts and AI Strategy in December 2025

International Business Machines Corporation (NYSE: IBM) is back in the M&A headlines. On December 8, 2025, IBM announced a definitive agreement to acquire data‑streaming specialist Confluent Inc. (NASDAQ: CFLT) in an all‑cash transaction valued at about $11 billion, or $31 per share.IBM Newsroom The deal lands after a year in which IBM shares have climbed a little over 40% year‑to‑date and are trading near record highs, powered by a renewed focus on hybrid cloud, AI, and mainframe cycles.Investing.com UK+1 Here’s a comprehensive look at where IBM stock stands today, what the Confluent acquisition means strategically and financially, and how Wall
8 December 2025
····
Visa Stock (V) Today: HSBC Upgrade, New Growth Bets and 2030 Forecasts

Visa Stock (V) Today: HSBC Upgrade, New Growth Bets and 2030 Forecasts

Visa Inc. (NYSE: V) heads into the U.S. session on December 8, 2025 as one of Wall Street’s most hotly debated “quality growth” stocks: richly valued, heavily owned by institutions, but backed by double‑digit earnings growth, powerful network effects and an aggressive push into AI‑driven and crypto‑enabled payments. Below is a comprehensive look at today’s news, current price, fresh forecasts out to 2030, and the main bull and bear arguments around Visa stock as of December 8, 2025. 1. Visa stock price today: where things stand on December 8, 2025 Visa shares last closed at about $331.24 on Friday, December
8 December 2025
·
GameStop (GME) Stock Today: Price, Q3 2025 Earnings Preview, Short Interest and Forecasts

GameStop (GME) Stock Today: Price, Q3 2025 Earnings Preview, Short Interest and Forecasts

GameStop Corp. (NYSE: GME) is back in the spotlight as investors brace for its fiscal Q3 2025 earnings report on Tuesday, December 9, with expectations for a return to revenue growth, rising profitability and another burst of volatility in a stock that still carries heavy short interest and a devoted retail base.TradingView+1 As of midday on December 8, 2025, GameStop shares trade around $23.00, giving the company a market capitalization of roughly $10.3 billion.Investing.com Despite a strong bounce from November lows, the stock remains down close to 30% year-to-date, reflecting a year dominated by macro headwinds, strategic uncertainty and renewed
8 December 2025
··
Strive Asset Management Stock (ASST): Bitcoin Treasury High‑Flyer Under Pressure – Latest News, Analysis and 2026 Outlook

Strive Asset Management Stock (ASST): Bitcoin Treasury High‑Flyer Under Pressure – Latest News, Analysis and 2026 Outlook

Updated December 8, 2025 This article is for informational purposes only and does not constitute investment advice. Always do your own research or consult a licensed adviser before making investment decisions. Snapshot: Why ASST Is Suddenly on Everyone’s Radar Strive, Inc. (Nasdaq: ASST), the parent of Strive Asset Management, has transformed from a small‑cap curiosity into one of the most talked‑about “Bitcoin treasury” stocks on the U.S. market. As of early trading on December 8, 2025, ASST is changing hands at roughly $0.90 per share, down nearly 8% in a single session, nearly 20% over the past week and more
8 December 2025
···
Energy Transfer LP (ET) Stock on December 8, 2025: Q3 Earnings, 8% Yield and LNG Delay Shape the Outlook

Energy Transfer LP (ET) Stock on December 8, 2025: Q3 Earnings, 8% Yield and LNG Delay Shape the Outlook

Note: This article is for informational and educational purposes only and is not investment advice. Energy Transfer LP Stock Snapshot on 8 December 2025 Energy Transfer LP (NYSE: ET), one of the largest U.S. midstream pipeline partnerships, is trading around $16.80 per unit in midday trading on December 8, 2025. That gives the partnership an equity value of roughly $57.6 billion and leaves the units a little over 20% below their 52‑week high of $21.45, set in January.MarketBeat+1 Over the past 12 months, ET units have delivered a negative total price return of about 10–11%, underperforming the broader U.S. equity
8 December 2025
·
Lumentum (LITE) Stock Hits Fresh Highs on AI Data Center Boom – Earnings, Forecasts and Risks as of December 8, 2025

Lumentum (LITE) Stock Hits Fresh Highs on AI Data Center Boom – Earnings, Forecasts and Risks as of December 8, 2025

Lumentum Holdings Inc. (NASDAQ: LITE) has quietly turned into one of 2025’s wildest AI-infrastructure stories. As of December 8, 2025, the stock is trading around $330–$340 per share, close to a new all‑time high after briefly touching $325.82 in recent sessions and soaring roughly 219% over the past year. StockAnalysis+1 At the same time, pretty much every kind of forecaster – Wall Street analysts, valuation models, and AI-driven prediction tools – is now arguing about whether Lumentum is a future compounder or a bubble in photonic form. Below is a structured look at the latest news, earnings, forecasts and valuation
8 December 2025
····
Paramount Skydance (PSKY) Stock Today: Netflix–Warner Bros. Deal Triggers a 16% Slide – What Comes Next for the New Hollywood Giant?

Paramount Skydance (PSKY) Stock Today: Netflix–Warner Bros. Deal Triggers a 16% Slide – What Comes Next for the New Hollywood Giant?

Date: December 8, 2025 Paramount Skydance Corporation (NASDAQ: PSKY) is starting this week under serious pressure. After losing a high‑stakes bidding war for Warner Bros. Discovery to Netflix, the newly merged media company has just logged one of the worst weekly performances in the S&P 500.Seeking Alpha+1 PSKY closed on Friday, December 5, at $13.37, down almost 10% on the day and roughly 16.5% over the past week, making it the index’s biggest percentage loser.StockAnalysis+1 Pre‑market quotes early Monday show only a modest bounce to around $13.47, suggesting investors are still digesting the fallout from the Netflix–Warner Bros. deal.StockAnalysis At
8 December 2025
·
1 … 455 456 457 458 459 … 535

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
LONDON, Feb 7, 2026, 20:00 GMT — Market closed AstraZeneca PLC (AZN) heads into next week’s trading with its New York-listed shares closing on Friday up 3.1% at $193.03, after-hours up a further 0.7% to $194.40. (Yahoo Finance) With markets shut on Saturday, the focus is Tuesday’s full-year and fourth-quarter 2025 report, which AstraZeneca said it will publish at 07:00 GMT, followed by an investor webcast at 11:45 GMT. (AstraZeneca) This matters now because the stock has drifted into earnings with little fresh company news on Friday itself, leaving guidance to do more of the heavy lifting. For AstraZeneca, the
Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

7 February 2026
Toyota shares rose 2% to 3,780 yen Friday after the company raised its full-year profit forecast and announced CFO Kenta Kon will replace CEO Koji Sato on April 1. Third-quarter net revenues climbed 6.8% to 38.087 trillion yen, but North America posted a 5.6 billion yen operating loss. Toyota’s U.S. ADRs closed up 2.9%. The tender offer for Toyota Industries shares closes Feb. 12.
Go toTop